Radiation induced oral mucositis

Indian Journal of Palliative Care

Volumn 15, Issue 2, 2009, Pages 95-102

  Satheesh Kumar, P S ^a   Balan, Anita ^a   Sankar, Arun ^b   Bose, Tinky ^a  

^a GOVERNMENT DENTAL COLLEGE   (India)

^b Regional Cancer Center   (India)

Author keywords

Mucositis; Oral cancer; Radiation

Indexed keywords

EID: 73849148246     PISSN: 09731075     EISSN: 19983735     Source Type: Journal    
DOI: 10.4103/0973-1075.58452     Document Type: Review

References (46)

1. Plevovia P. Prevention and treatment of chemotherapy and radiotherapy induced oral mucositis: A review. Oral Oncol 1999;35:453-470
2. Berger AM, Kilroy TJ. Oral complications. In: Cancer: Principles and practice of oncology. In: DeVita VT, Hellman S, Rosenberg SA, editors. 5th ed. Philadelphia: J B Lippincott; 1997. p. 2714-2725
3. Lalla RV, Peterson DE. Oral mucositis. Dent Clin North Am 2005;49:167-184
4. Treister N, Sonis S. Mucositis: Biology and management. Curr Opin Otolaryngol Head Neck Surg 2007;15:123-129
5. Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of allogenic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer 2007;15:491-496 (Pubitemid 46570780)
6. Vera-Llonch M, Oster G, Hagiwara M, Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 2006;106:329-336
7. Logan RM, Gibson RJ, Sonis ST, Keefe DM. Nuclear factor-kappa B (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol 2007;43:395-401.
8. Gibson RJ, Bowen JM, Cummins AG, Logan R, Healey T, Keefe DM. Ultrastructural changes occur early within the oral mucosa following cancer chemotherapy [abstract A-373]. Support Care Cancer 2004;12:389.
9. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004;100:1995-2025.
10. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004;100:1995-2025.
11. Sonis ST, Peterson RL, Edwards LJ, Lucey CA, Wang L, Mason L, et al. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol 2000;36:373-381
12. Dorr W, Emmendorfer H, Haide E. Proliferation equivalent of 'accelerated repopulation' in mouse oral mucosa. Int J Radiat Biol 1994;66:157-167
13. Epstein JB, Gorsky M, Guglietta A, Le N, Sonis ST. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy. Cancer 2000;89:2258-2265
14. Dodd MJ, Miaskowski C, Greenspan D, MacPhail L, Shih AS, Shiba G, et al. Radiation-induced mucositis: A randomized clinical trial of micronized sucralfate versus salt and soda mouthwashes. Cancer Invest 2003;21:21-33.
15. Nottage M, McLachlan SA, Brittain MA, Oza A, Hedley D, Feld R, et al. Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: A randomized, placebo-controlled trial. Support Care Cancer 2003;11:41-47
16. Barclay L. Morphine mouthwash relieves pain of oral mucositis. Cancer 2002;95:2230-2236
17. Spijkevet FK, van Saene JJ, Panders AK, Vermy A, Mehta DM, Filder V. Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients. J Surg Oncol 1991;46:167-173
18. Matthews RH, Ercal N. Prevention of mucositis in irradiated head and neck cancer patients. J Exp Ther Oncol 1996;1:135-138
19. Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: A randomized controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 1994;308:93-97
20. Yoneda S, Imai S, Hanada N, Yamazaki T, Senpuku H, Ota Y, et al. Effects of oral care on development of oral mucositis and microorganisms in patients with esophageal cancer. Jpn J Infect Dis 2007;60:23-28
21. McGuire DB, Correa ME, Johnson J, Wienandts P. The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer 2006;14:541-547
22. Barker G, Loffus L, Cuddy P, Barker B. The effects of of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis. Oral Surg Oral Med Oral Pathol 1991;71:288-293
23. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004;351:2590-2598
24. von Bultzingslowen I, Brennan MT, Spijkervet FK, Logan R, Stringer A, Raber-Durlacher JE, et al. Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis. Support Care Cancer 2006;14:519-527
25. Lalla RV. Velafermin (CuraGen). Curr Opin Investig Drugs 2005;6:1179-1185
26. Rosen LS, Abdi E, Davis ID, Gutheil J, Schnell FM, Zalcberg J, et al. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol 2006;24:5194-5200
27. Epstein JB, Silverman S Jr, Paggiarino DA, Crockett S, Schubert MM, Senzer NN, et al. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: Results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 2001;92:875-885
28. Lalla RV, Schubert MM, Bensadoun RJ, Keefe D. Anti-inflammatory agents in the management of alimentary mucositis. Support Care Cancer 2006;14:558-565
29. Coeffier M, Marion R, Leplingard A, Lerebours E, Ducrotté P, Déchelotte P. Glutamine decreases interleukin-8 and interleukin-6 but not nitric oxide and prostaglandins e production by human gut in vitro. Cytokine 2002;18:92-97
30. Evans ME, Jones DP, Ziegler TR. Glutamine prevents cytokine-induced apoptosis in human colonic epithelial cells. J Nutr 2003;133:3065-3071
31. Bellon G, Monboisse JC, Randoux A, Borel JP. Effects of preformed proline and proline amino acid precursors (including glutamine) on collagen synthesis in human fibroblast cultures. Biochim Biophys Acta 1987;930:39-47.
32. Peterson DE, Jones JB, Petit RG 2nd. A Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer 2007;109:322-331
33. Pytlik R, Benes P, Patorkova M, Chocenská E, Gregora E, Procházka B, et al. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: A randomized, doubleblind, placebo controlled study. Bone Marrow Transplant 2002;30:953-961
34. Mantovani G, Maccio A, Madeddu C, Mura L, Massa E, Gramignano G, et al. Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients, Impact of an antioxidant treatment. J Environ Pathol Toxicol Oncol 2003;22:17-28.
35. Bensadoun RJ, Schubert MM, Lalla RV, Keefe D. Amifostine in the management of radiation induced and chemo-induced mucositis. Support Care Cancer 2006;14:566-572
36. Barasch A, Peterson DE, Tanzer JM, D Ambrosio JA, Nuki K, Schubert MM, et al. Helium-neon laser effects on conditioning induced oral mucositis in bone marrow transplantation patients. Cancer 1995;76:2550-2556
37. Mills EE. The modifying effect of beta-carotene on radiation and radiotherapy and chemotherapy induced oral mucositis. Br J Cancer 1988;57:416-417
38. Bianco JA, Appelbaum FR, Nemunaitis J, Almgren J, Andrews F, Kettner P, et al. Phase I-II trial of pentoxifyline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 1991;78:1205-1211
39. Clift RA, Bianco JA, Appelbaum FR, Buckner CD, Singer JW, Bakke L, et al. A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation. Blood 1993;82:2025-2030
40. Mose S, Adametz IA, Saran F, Thilmann C, Hayd R, Knecht R, et al. Can Prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis. Am J Clin Oncol 1997;20:407-411
41. Hermann F, Schuiz G, Weser M, Kolbe K, Nicolay U, Noack M, et al. Effect of granulocyte-macrophage colony stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy. Am J Med 1990;88:619-624
42. Gluckman E, Lotsberg J, Devergie A, Zhao XM, Melo R, Gomez-Morales M, et al. Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation. J Antimicrob Chemother 1983;12:161-167
43. Kaanders JH, Fleming TJ, Ang KK, Maor MH, Peters LJ. Devices valuable in head and neck radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:639-645
44. Dahiya MC, Redding SW, Dahiya RS, Eng TY, Kirkpatrick WR, Coco BJ, et al. Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003;57:79-83.
45. Bensadoun RJ, Franquin JC, Ciais G, Darcourt V, Schubert MM, Viot M, et al. Low-energy He/Ne laser in the prevention of radiation-induced mucositis: A multicenter phase III randomized study in patient's with head and neck cancer. Support Care Cancer 1999;7:244-252
46. Migliorati CA, Oberle-Edwards L, Schubert M. The role of alternative and natural agents, cryotherapy, and/or laser for management of alimentary mucositis. Support Care Cancer 2006;14:533-540